Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.
 

Effect of Experimental Drug S107 on Accessory Protein Binding to the RyR

Loading...
Thumbnail Image

View/Download File

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Effect of Experimental Drug S107 on Accessory Protein Binding to the RyR

Published Date

2012-04-18

Publisher

Type

Presentation

Abstract

The physiological basis of muscle-generated motor activity depends on the precise regulation of intracellular Ca2+ ions. Central to this process is the sarcoplasmic reticulum (SR), a special organelle in muscle cells that is responsible for ion storage. The Ca2+ ions are released from the SR through a large conductance channel known as the ryanodine receptor (RyR). The channel’s activity is in turn regulated by intracellular messengers, including FK506 binding proteins (FKBP12.6 & 12.0), and calmodulin (CaM). The experimental heart failure drug S107 has been associated with improved muscle performance, though it is still unclear if it directly affects the binding activity of either the FKBPs or CaM. Here, the effect of S107 on the binding of fluorescent FKBPs and CaM to RyR is characterized. The results show that S107 slightly, but significantly, decreases the binding affinity of CaM; though, only in nanomolar calcium concentrations, and when the RyR is treated with oxidized glutathione. S107 has no significant effect on the binding of FKBP to RyR. Prior to this research, it was thought that S107 might significantly increase the binding affinity of FKBP. The effect of S107 on CaM binding to RyR has not been previously investigated. These results suggest that the primary mechanism through which S107 achieves its physiological effects does not require or affect FKBP binding. Further studies will have to determine whether the effect of S107 on CaM binding to RyR is linked to the inhibition of Ca2+ leak in the channel.

Description

Faculty adviser: Razvan Cornea

Related to

Replaces

License

Series/Report Number

Funding information

This research was supported by the Undergraduate Research Opportunities Program (UROP). Also, National Institutes of Health (Grant HL92097)

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Popa, Mircea Anton. (2012). Effect of Experimental Drug S107 on Accessory Protein Binding to the RyR. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/123409.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.